Search the web
Sign In
New User? Sign Up
frontline-hepatitis-awareness · Frontline Hepatitis Awareness
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Message search is now enhanced, find messages faster. Take it for a spin.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Incidence of hepatocellular carcinoma among individuals with hepati   Message List  
Reply | Forward Message #9995 of 15133 |

Journal of Viral Hepatitis (OnlineEarly Articles).
doi:10.1111/j.1365-2893.2007.00893.x

Prev Article Next Article
Abstract
Incidence of hepatocellular carcinoma among individuals with hepatitis B virus
infection identified using an automated data algorithm

M. Ulcickas Yood1,2,31Josephine Ford Cancer Center, Henry Ford Health System,
Detroit, MI2Epidemiology and Public Health, Yale University School of Medicine,
New Haven, CT3EpiSource, Hamden, CT, C. P. Quesenberry Jr44Division of Research,
Kaiser Permanente Medical Care Program, Oakland, CA, D. Guo5,65Global
Epidemiology and Outcomes Research, Bristol Myers Squibb Company, Wallingford,
CT6Global Epidemiology and Outcomes Research, Bristol Myers Squibb Company,
Plainsboro, NJ, K. Wells11Josephine Ford Cancer Center, Henry Ford Health
System, Detroit, MI, J. Shan44Division of Research, Kaiser Permanente Medical
Care Program, Oakland, CA, L. Sanders5,65Global Epidemiology and Outcomes
Research, Bristol Myers Squibb Company, Wallingford, CT6Global Epidemiology and
Outcomes Research, Bristol Myers Squibb Company, Plainsboro, NJ, M. L.
Skovron5,65Global Epidemiology and Outcomes Research, Bristol Myers Squibb
Company, Wallingford, CT6Global Epidemiology and Outcomes Research, Bristol
Myers Squibb Company, Plainsboro, NJ, U. Iloeje5,65Global Epidemiology and
Outcomes Research, Bristol Myers Squibb Company, Wallingford, CT6Global
Epidemiology and Outcomes Research, Bristol Myers Squibb Company, Plainsboro,
NJ, C. Caldwell77Yale New Haven Hospital, New Haven, CT, USA and M. M.
Manos44Division of Research, Kaiser Permanente Medical Care Program, Oakland,
CA1Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI;
2Epidemiology and Public Health, Yale University School of Medicine, New Haven,
CT; 3EpiSource, Hamden, CT; 4Division of Research, Kaiser Permanente Medical
Care Program, Oakland, CA; 5Global Epidemiology and Outcomes Research, Bristol
Myers Squibb Company, Wallingford, CT; 6Global Epidemiology and Outcomes
Research, Bristol Myers Squibb Company, Plainsboro, NJ; and 7Yale New Haven
Hospital, New Haven, CT, USA
Marianne Ulcickas Yood DSc, MPH, 275 Blue Trail, Suite 3, Hamden, CT 06518, USA.

E-mail: muyood@...

Summary. The purpose of this study was to develop an algorithm for identifying
patients with chronic hepatitis B virus (HBV) using automated data sources from
two US health systems and evaluate the algorithm’s performance by quantifying
the incidence of hepatocellular carcinoma (HCC) among chronic HBV patients. To
allow comparisons with estimates from automated databases that may not contain
all data elements used in this algorithm, we created three definitions of
chronic HBV infection and used these definitions to create three overlapping
cohorts. We compared the incidence of HCC in each cohort with the incidence of
HCC in a matched general population comparison cohort with no evidence of HBV.
Patients who met the most stringent criteria for chronic HBV infection (based on
the standard definition of 6 months of infection using repeat laboratory tests
and record review) were 146 times more likely to develop HCC than matched
comparison patients (adjusted hazard ratio = 146.5, 95% CI: 74.0–289.8). Those
not meeting the stringent criteria, but who met the criterion of at least one
positive hepatitis B surface antigen test were 30 times more likely to develop
HCC than comparison patients (adjusted hazard ratio = 29.8, 95% CI: 16.5–53.6).
Finally, patients who met the criterion based on at least one HBV diagnosis were
38 times more likely to develop HCC than matched comparison patients (adjusted
hazard ratio = 37.8, 95% CI: 25.9–55.1). The magnitude of the relative increase
in HCC risk seen using different criteria used to define HBV infection indicate
that these automated data algorithms can identify patients with chronic HBV
infection.

http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2007.00893.x
_________________________________________________________________
Peek-a-boo FREE Tricks & Treats for You!
http://www.reallivemoms.com?ocid=TXT_TAGHM&loc=us


Tue Oct 2, 2007 10:23 am

mamablondie
Offline Offline
Send Email Send Email

Forward
Message #9995 of 15133 |
Expand Messages Author Sort by Date

Journal of Viral Hepatitis (OnlineEarly Articles). doi:10.1111/j.1365-2893.2007.00893.x Prev Article Next Article Abstract Incidence of hepatocellular...
shereemartin Martin
mamablondie
Offline Send Email
Oct 2, 2007
10:24 am

Journal of Viral Hepatitis 15 (1), 28–36. doi:10.1111/j.1365-2893.2007.00893.x Abstract Incidence of hepatocellular carcinoma among individuals with...
shereemartin Martin
mamablondie
Offline Send Email
Dec 11, 2007
12:55 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help